Document is current
Any future updates will be listed below
-
Authors
Tadros, Rafik https://orcid.org/0000-0002-1472-0258
Zheng, Sean L. https://orcid.org/0000-0002-5762-6392
Grace, Christopher
Jordà, Paloma https://orcid.org/0000-0002-9236-1713
Francis, Catherine
West, Dominique M.
Jurgens, Sean J. https://orcid.org/0000-0002-1605-9782
Thomson, Kate L. https://orcid.org/0000-0003-2807-3431
Harper, Andrew R. https://orcid.org/0000-0001-5327-0328
Ormondroyd, Elizabeth https://orcid.org/0000-0002-9116-4064
Xu, Xiao
Theotokis, Pantazis I. https://orcid.org/0000-0001-8718-230X
Buchan, Rachel J. https://orcid.org/0000-0003-2490-9289
McGurk, Kathryn A. https://orcid.org/0000-0002-5445-6906
Mazzarotto, Francesco https://orcid.org/0000-0002-6159-9980
Boschi, Beatrice
Pelo, Elisabetta
Lee, Michael https://orcid.org/0000-0002-0186-4439
Noseda, Michela https://orcid.org/0000-0002-9553-5029
Varnava, Amanda
Vermeer, Alexa M. C.
Walsh, Roddy https://orcid.org/0000-0001-5092-8825
Amin, Ahmad S. https://orcid.org/0000-0002-1600-7907
van Slegtenhorst, Marjon A.
Roslin, Nicole M. https://orcid.org/0000-0002-4609-8299
Strug, Lisa J. https://orcid.org/0000-0003-0503-9740
Salvi, Erika https://orcid.org/0000-0002-2724-2291
Lanzani, Chiara
de Marvao, Antonio https://orcid.org/0000-0001-9095-5887
,
Cusi, Daniele
Manunta, Paolo
Citterio, Lorena
Glorioso, Nicola
Roberts, Jason D.
Tremblay-Gravel, Maxime
Giraldeau, Genevieve
Cadrin-Tourigny, Julia
L’Allier, Philippe L.
Garceau, Patrick
Talajic, Mario
Gagliano Taliun, Sarah A. https://orcid.org/0000-0003-1306-1868
Pinto, Yigal M. https://orcid.org/0000-0002-2836-571X
Rakowski, Harry
Pantazis, Antonis
Bai, Wenjia https://orcid.org/0000-0003-2943-7698
Baksi, John
Halliday, Brian P.
Prasad, Sanjay K.
Barton, Paul J. R. https://orcid.org/0000-0002-1165-7767
O’Regan, Declan P. https://orcid.org/0000-0002-0691-0270
Cook, Stuart A.
de Boer, Rudolf A. https://orcid.org/0000-0002-4775-9140
Christiaans, Imke https://orcid.org/0000-0001-5799-2344
Michels, Michelle
Kramer, Christopher M.
Ho, Carolyn Y. https://orcid.org/0000-0002-7334-7924
Neubauer, Stefan
,
Abraham, Theodore
Anderson, Lisa
Andre, Florian
Appelbaum, Evan
Autore, Camillo
Baldassarre, Lauren
Berry, Colin
Biagini, Elena
Bradlow, William
Bucciarelli-Ducci, Chiara
Chiribiri, Amedeo
Choudhury, Lubna
Crean, Andrew
Dawson, Dana
Desai, Milind
Desvigne-Nickens, Patrice
DiMarco, John
Elstein, Eleanor
Flett, Andrew
Friedrich, Matthias
Gelfand, Eli
Geller, Nancy
Germans, Tjeerd
Geske, Jeffrey
Hays, Allison
Heitner, Stephen B.
Helms, Adam
Jacoby, Daniel
Kim, Dong-Yun
Kim, Bette
Kim, Han
Kolm, Paul
Kwong, Raymond
Larose, Eric
Madias, Christopher
Mahmod, Masliza
Mahrholdt, Heiko
Maron, Martin
Masri, Ahmad
McCann, Gerry
Mohiddin, Saidi
Mongeon, Francois-Pierre
Nagueh, Sherif
Newby, David
Nightingale, Angus
Owens, Anjali
Plein, Sven
Raman, Betty
Rimoldi, Ornella
Salerno, Michael
Schulz-Menger, Jeanette
Sharma, Sanjay
Sherrid, Mark
van Rossum, Albert
Weinsaft, Jonathan
Weintraub, William
White, James
Williamson, Eric
Woo, Anna
Matthews, Paul M. https://orcid.org/0000-0002-1619-8328
Wilde, Arthur A. M.
Tardif, Jean-Claude https://orcid.org/0000-0002-8200-8983
Olivotto, Iacopo
Adler, Arnon
Goel, Anuj
Ware, James S. https://orcid.org/0000-0002-6110-5880
Bezzina, Connie R. https://orcid.org/0000-0002-0633-3514
Watkins, Hugh https://orcid.org/0000-0002-5287-9016
- License Information
-
More Information
Article History
Received: 25 January 2023
Accepted: 10 January 2025
First Online: 18 February 2025
Competing interests
: R.T. has received research support and consultancy fees from Bristol Myers Squibb. A.R.H. is a current employee and stockholder of AstraZeneca. D.P.O. has received grants and consultancy fees from Bayer. R.d.B. has received research grants and/or fees from AstraZeneca, Abbott, Boehringer Ingelheim, Cardior Pharmaceuticals GmbH, Ionis Pharmaceuticals, Inc., Novo Nordisk and Roche, and also has speaker engagements with Abbott, AstraZeneca, Bayer, Bristol Myers Squibb, Novartis and Roche. P.G. receives research funds from Abbott Cardiovascular and Medtronics. M.M. has received research support or consultancy fees from Bristol Myers Squibb, Cytokinetics, Pfizer, Sanofi Genzyme, Biomarin and Alnylam. C.M.K. received research grants from Cytokinetics and Bristol Myers Squibb. P.M.M. has received consultancy fees from Roche, Biogen, Nodthera and Sangamo Pharmaceuticals and has received research or educational funds from Biogen, Novartis, Merck and Bristol Myers Squibb. J.-C.T. has received research grants from Amarin, AstraZeneca, Ceapro, DalCor, Esperion, Ionis, Novartis, Pfizer and RegenXBio; honoraria from AstraZeneca, DalCor, HLS Therapeutics, Pendopharm and Pfizer; holds minor equity interest in DalCor; and is an author of a patent on pharmacogenomics-guided CETP inhibition. J.S.W. has received research support or consultancy fees from Myokardia, Bristol Myers Squibb, Pfizer and Foresite Labs. C.R.B. has consulted for Illumina. H.W. has consulted for Cytokinetics, BridgeBio and BioMarin. The remaining authors declare no competing interests.
